• Skip to primary navigation
  • Skip to main content
Engineered Tissue Solutions

Engineered Tissue Solutions

  • Chronic Wound Care
    • Mirragen
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Surgical Wound Care
    • MirraSurg
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Science & Technology
  • Provider & Patient Support
    • For Providers
    • For Patients
    • Reimbursement
  • About
    • Contact Us
    • News & Events
    • Careers
    • Testimonials
  • Request Information

Case Study: DFU – Transmetatarsal Amputation – TMA


Patient History

  • 62-year-old with wound complications following right-foot TMA.
  • Stroke with left sided weakness
  • End stage renal disease on dialysis
  • Myocardial infarction
  • Hypertension
  • Peripheral vascular disease
  • Diabetes

Treatment

Previous Treatments:

  • Atherectomy, angioplasty of distal SFA & popliteal artery
  • Embolectomy of distal popliteal artery
  • Surgical debridement
  • NPWT


Outcome:
 

  • Mirragen applied and wound closed after 9 applications
3-1-2023
9-15-2023
10-27-2023
12-29-2023

Learn how ETS is transforming wound care.

Access Literature
  • Request Information
  • Contact Us
  • Careers
  • LinkedIn
  • Facebook
  • Instagram
  • Disclaimer
  • Privacy
  • Terms & Conditions
  • Patents

MIRRAGEN® is a registered trademark of ETS Tech Holdings, LLC. | © ETS Wound Care